PDL BioPharma, Inc. Free Cash Flow Yield

Free Cash Flow Yield of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow Yield growth rates and interactive chart.


Highlights and Quick Summary

Current Free Cash Flow Yield of PDL BioPharma, Inc. is 18.26% (as of December 30, 2019)
  • Free Cash Flow Yield for the quarter ending June 29, 2020 was -2.19% (a -110.18% decrease compared to previous quarter)
  • Year-over-year quarterly Free Cash Flow Yield decreased by -108.12%
  • Annual Free Cash Flow Yield for 2019 was 18.26% (a 5.86% increase from previous year)
  • Annual Free Cash Flow Yield for 2018 was 17.25% (a -47.52% decrease from previous year)
  • Annual Free Cash Flow Yield for 2017 was 32.87% (a 4.61% increase from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow Yield of PDL BioPharma, Inc.

Most recent Free Cash Flow Yieldof PDLI including historical data for past 10 years.

Interactive Chart of Free Cash Flow Yield of PDL BioPharma, Inc.

PDL BioPharma, Inc. Free Cash Flow Yield for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -2.19% 21.51%
2019 18.26% 26.97% 22.72% 17.79% 18.26%
2018 17.25% 17.16% 24.43% 17.81% 17.25%
2017 32.87% 33.52% 25.25% 19.28% 32.87%
2016 31.42% 32.48% 38.6% 48.94% 31.42%
2015 39.74% 18.17% 27.72% 25.72% 39.74%
2014 25.71% 9.13% 2.95% 5.35% 25.71%
2013 22.85% 23.54% 23.14% 24.11% 22.85%
2012 21.6% 18.56% 21.8% 22.22% 21.6%
2011 19.7% 19.95% 18.13% 17.81% 19.7%
2010 0.0% 0.0% 0.0% 0.0%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.